From: Clinical impact of advanced chronic kidney disease in patients with non-HIV pulmonary cryptococcosis
 | eGFR > 45 | eGFR ≤45 | p value |
---|---|---|---|
Limited in one lobe | 24 (57.1%) | 4 (28.6%) | 0.06 |
Unilateral lung field | 32 (76.2%) | 7 (50.0%) | 0.07 |
Single nodule | 6 (14.3%) | 1 (7.1%) | 0.46 |
Multiple nodules | 27 (64.3%) | 10 (71.4%) | 0.62 |
Mass | 3 (7.1%) | 1 (7.1%) | 1 |
Cavitation | 6 (14.3%) | 1 (7.1%) | 0.46 |
Consolidation | 8 (19.0%) | 3 (21.4%) | 0.85 |
Ground glass attenuation | 0 (0.0%) | 1 (7.1%) | 0.09 |
Pleural effusion | 1 (2.4%) | 3 (21.4%) | 0.03 |